N-acetyltryptamine,
N-acetyltryptamine monohydrochloride,
N-Acetyltryptamine,
1016-47-3,
N-(2-(1H-indol-3-yl)ethyl)acetamide,
N-[2-(1H-Indol-3-yl)ethyl]acetamide,
Acetamide, N-[2-(1H-indol-3-yl)ethyl]-,
3-(2-N-Acetylaminoethyl)indole,
CHEMBL33171,
CHEBI:55515,
NVUGEQAEQJTCIX-UHFFFAOYSA-N,
MFCD00209910,
N-[2-(1H-Indol-3-yl)-ethyl]-acetamide,
Acetamide, N-(2-(1H-indol-3-yl)ethyl)-,
SMR000686036,
SR-01000075685,
Acetotryptamide,
Acetamide, N-(2-indol-3-ylethyl)-,
Tocris-0357,
AC1L2EBK,
Lopac-A-7342,
N-Acetyltryptamine, powder,
AC1Q1L6A,
3-(2-Acetamidoethyl)indole,
Lopac0_000101,
MLS001250169,
MLS002153204,
SCHEMBL468850,
AC1Q5P72,
ISUPSL100255,
ACon1_000465,
CTK8G1571,
N-(2-indol-3-ylethyl)acetamide,
DTXSID30144042,
HMS2270O21,
HMS3260E04,
HMS3266I05,
HMS3675G05,
ZINC174849,
KS-000017TN,
Tox21_500101,
0428AA,
BDBM50282758,
PDSP1_001815,
PDSP2_001798,
STL352108,
AKOS000639631,
CCG-204196,
LP00101,
MCULE-3484861085,
NCGC00015088-01,
NCGC00015088-02,
NCGC00015088-03,
NCGC00015088-04,
NCGC00015088-05,
NCGC00015088-06,
NCGC00015088-07,
NCGC00015088-08,
NCGC00015088-09,
NCGC00024552-01,
NCGC00024552-02,
NCGC00024552-03,
NCGC00024552-04,
NCGC00024552-05,
NCGC00024552-06,
NCGC00260786-01,
AJ-17612,
ZB009323,
N-[2-(1H-Indol-3-yl)ethyl]acetamide #,
B6274,
EU-0033445,
EU-0100101,
ST50409166,
A 7342,
Acetamide, N-(2-indol-3-ylethyl)- (7CI,8CI),
Acetotryptamide N-Acetyl-2-(indol-3-yl)ethylamine,
Acetamide, N-[2-(1H-indol-3-yl)ethyl]- (9CI),
J-000457,
SR-01000075685-1,
SR-01000075685-2,
SR-01000075685-4,
BRD-K73700643-001-04-7,
BRD-K73700643-001-10-4,
NCGC00015088-09_C12H14N2O_N-[2-(1H-Indol-3-yl)ethyl]acetamide,
374572-55-1,
7AN,
C12H14N2O,
CID70547,
AR-1K3534,
C12-H14-N2-O,
~{n}-[2-(1~{h}-Indol-3-Yl)ethyl]ethanamide,
A2685,
19231-22-2,